OR WAIT null SECS
Rita C. Peters is editorial director of BioPharm International, Pharmaceutical Technology, and Pharmaceutical Technology Europe.
Philadelphia plays host to the exhibits, conferences, and networking activities of CPhI North America on May 16-18, 2017.
In my role as editorial director of a bio/pharmaceutical industry publication, I attend many trade shows and conferences. The largest events, sponsored by CPhI, a sister brand of BioPharm Internationalat UBM plc, have a long track record of gathering pharmaceutical development and manufacturing buyers and sellers in one location to hear about the latest trends, network, and conduct business. On May 16-18, 2017, the CPhI brand will host CPhI North America in Philadelphia, PA, bringing together bio/pharma experts from the United States, Canada, and beyond. The following are some highlights.
The CPhI North America exhibition will be home to more than 600 global companies including API and excipient suppliers, packaging and drug delivery suppliers, small- and large-molecule contract development and manufacturing organizations, as well as equipment and other contract service providers. A co-located event, InformEx, features suppliers in fine and specialty chemical markets, including biopharmaceuticals, medical devices, and green chemistry.
In educational programming, CPhI Connect features keynote and master class sessions focused on drug development, drug manufacturing, outsourcing, and quality and regulatory issues. Topics include: accelerating product development; legal and policy strategies; improving drug R&D productivity; novel container/closure technologies; bioconjugates and biotherapeutics; economies of capability vs. economies of scale; track and trace in a post-serialized world; biophysical characterization of protein therapeutics; continuous biopharmaceutical manufacturing; pharmaceutical impurities; good supply practices; and quality metrics.
In Insight Briefing sessions, attendees can listen to updates on technical and business issues. Topics include formulation techniques for controlled-release powders to create patient-friendly products; liquid stick packs for unit dosing; process safety evaluations for contract development and manufacturing API operations; worker protection in life-science laboratory and production environments; and bio/pharma business opportunities in the Middle East-North Africa region. The briefings will be held in the Insight Briefings Theater during the three days of CPhI North America; admission is free to anyone with an exhibition, conference, or exhibitor badge.
During a briefing on May 17 at 2:30 pm the editors of BioPharm International and Pharmaceutical Technology will release the results of a study on quality practices in drug development and manufacturing organizations serving the US market. The briefing, based on a comprehensive survey and additional research, will reveal current quality-related practices in bio/pharma organizations and contract manufacturers producing drug products for patients in the US.
In another highlighted session, bio/pharma industry expert Jim Miller, president of PharmaSource Information Services, will share his perspective on the contract services landscape and suggest strategies for outsourcing companies looking to grow in this sector in the session The Contract Services Market: Status and Strategies. BioPharm International and Pharmaceutical Technology will host this special session on Wednesday, May 17, from 8:30-10 am, in the conference area of the Pennsylvania Convention Center.
For more details on the exhibition, conference, briefings, or networking opportunities at the event, visit www.cphinorthamerica.com.
The editors of BioPharm International will be at CPhI North America, booth 2640. See you there!
Vol. 30, No. 4
When referring to this article, please cite it as R. Peters, “Now Arriving: CPhI North America," BioPharm International 30 (4) 2017.